The Cost Effectiveness of Chlorofluorocarbon-Free Beclomethasone Dipropionate in the Treatment of Chronic Asthma: A Cost Model Based on a 1-Year Pragmatic, Randomised Clinical Study

Author： Price D.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.20, Iss.10, 2002-01, pp. : 653-664

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A 1-Year Prospective Cost-Effectiveness Analysis of Roflumilast for the Treatment of Patients with Severe Chronic Obstructive Pulmonary Disease

By Mölken Maureen P.M.H. Rutten-van  

PharmacoEconomics, Vol. 25, Iss. 8, 2007-01 ,pp. : 695-711

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness and Cost-Utility of Beclomethasone/Formoterol versus Fluticasone Propionate/Salmeterol in Patients with Moderate to Severe Asthma

By Gerzeli Simone  

Clinical Drug Investigation, Vol. 32, Iss. 4, 2012-04 ,pp. : 253-265

Adis International

Access to resources Recommend Favorite

A cost-effectiveness model of smoking cessation based on a randomised controlled trial of varenicline versus placebo in patients with chronic obstructive pulmonary disease

By Lock Kevin   Wilson Koo   Murphy Daniel   Riesco Juan Antonio  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 17, 2011-12 ,pp. : 2613-2626

Informa Healthcare

Access to resources Recommend Favorite

From Randomised Clinical Trials to Clinical Practice: A Pragmatic Cost-Effectiveness Analysis of Paclitaxel in First-Line Therapy for Advanced Ovarian Cancer

By Samuel Limat  

PharmacoEconomics, Vol. 22, Iss. 10, 2004-01 ,pp. : 633-641

Adis International

Access to resources Recommend Favorite

HFA-beclomethasone cost effective for asthma in the UK

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 376, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite